Clinical Trial

Total-body Glucose Utilization in Obesity

Study acronym: TOTAL
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
There are three goals for this study. One is to investigate how different emotions and exposure to cold affect blood flow in the body. The second aim is to study how insulin affects blood flow and tissue glucose uptake, and to study whether this effect is altered in obesity. Last, the study focuses on establishing the lowest dose of a PET radiotracer, oxygen-15 labelled water, that can be used in clinical studies with a new whole-body PET scanner.
Trial Details
NCT Number NCT06739473
Lead Sponsor Turku University Hospital
Conditions Obesity and Overweight
Enrollment 60 participants
Start Date 2023-01-25
Primary Completion 2024-12 (estimated)
Study Completion 2024-12 (estimated)
Updated on ClinicalTrials.gov 2024-12-18